Entry Point Capital, LLC Bio Rad Laboratories, Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 148 shares of BIO stock, worth $45,866. This represents 0.05% of its overall portfolio holdings.
Number of Shares
148Holding current value
$45,866% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
486Shares Held
17.8MCall Options Held
44.9KPut Options Held
79.7K-
Vanguard Group Inc Valley Forge, PA2.42MShares$750 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.48MShares$459 Million0.01% of portfolio
-
Veritas Asset Management LLP1.15MShares$355 Million3.33% of portfolio
-
State Street Corp Boston, MA874KShares$271 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA515KShares$160 Million0.84% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.63B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...